Bioventus Inc. (BVS) NASDAQ

7.02

+0.31(+4.62%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap686.23M
Enterprise Value980.27M
P/E Ratio-2,954.64
PEG Ratio-29.93
Price/Sales Ratio0.83
Price/Book Ratio2.9
Enterprise/Revenue1.38
Enterprise/EBITDA9.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 28, 2025

Profitability

Profit Margin-0
Operating Margin0.06

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue573.28M
Revenue/Share8.48
Gross Profit388.23M
EBITDA-49.56M
Net Income-33.54M
Diluted EPS-0.75

Balance Sheet

Total Cash32.91M
Total Cash/Share0.49
Total Debt341.24M
Total Debt/Equity2.12
Current Ratio1.48
Book Value Per Share3.03

Price History

52-Week Change-39.85
52-Week High14.38
52-Week Low5.81
Moving Average 50 Days6.98
Moving Average 200 Days8.13

Statistics

Average Volume422,300
Shares Outstanding66.89M
% Held by Institutions70.75

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A